Dow Up 0.11% Nasdaq Up 0.50%

Novo Nordisk A/S (NVO)

-NYSE
45.96 Up 0.29(0.63%) Aug 29, 4:04PM EDT
Prev Close:45.67
Open:45.77
Bid:45.00 x 100
Ask:46.70 x 200
1y Target Est:49.37
Beta:1.04
Next Earnings Date:N/A
Day's Range:45.67 - 46.00
52wk Range:32.20 - 48.42
Volume:878,259
Avg Vol (3m):892,926
Market Cap:120.82B
P/E (ttm):26.44
EPS (ttm):1.74
Div & Yield:0.61 (1.30%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVOUp 0.63%120.82B
LLYUp 0.71%68.12B
PFEUp 0.03%186.36B
SNY 0.00%143.54B

Key Statistics

Forward P/E (1 yr):22.64
P/S (ttm):8.06
Ex-Dividend Date:21-Mar-14

Analysts

Annual EPS Est (Dec-14) :1.82
Quarterly EPS Est (Jun-14) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):2.09

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback